Relative Contraindications for Right-Sided Jugular Central Venous Catheter Placement

Anatomical Contraindications

The primary relative contraindications for placing a right-sided jugular central venous catheter include previous thrombosis of the right internal jugular vein, anatomical abnormalities, local infection or trauma at the insertion site, and presence of tracheostomy, according to Praxis Medical Insights 1, 2
Previous thrombosis or stenosis of the right internal jugular vein increases risk of catheter dysfunction and potential for embolization during insertion 2
Significant distortion of neck anatomy due to surgery, radiation, or congenital abnormalities makes identification of landmarks difficult 1
Presence of a permanent pacemaker or implantable cardioverter-defibrillator on the right side is a relative contraindication 1

Local infection or inflammation at the intended insertion site increases risk of catheter-related bloodstream infection 2
Recent trauma or surgery to the right neck or clavicular region is a relative contraindication 1, 2
Presence of a tracheostomy tube increases infection risk due to proximity to the insertion site 2
Coagulopathy or thrombocytopenia increases bleeding risk during insertion 3

Left-sided placements are associated with higher incidence of deep vein thrombosis than right-sided catheters 4
The right internal jugular vein provides a straighter, more direct course to the SVC, resulting in easier catheter positioning and fewer complications 1

The optimal catheter tip position is in the lower third of the SVC, at the atrio-caval junction, or in the upper portion of the right atrium 5, 6

Ultrasound-guided venepuncture is strongly recommended for all CVC insertions as it is associated with lower incidence of complications and higher success rates than 'blind' venepuncture 5, 7
The femoral vein is relatively contraindicated for central venous access due to high risk of infection and catheter-related venous thrombosis 6, 7

The contralateral (left) internal jugular vein should be considered as the first alternative site, particularly when using ultrasound guidance to confirm vessel patency 2
The subclavian vein approach can be used as an alternative, though it carries a higher risk of mechanical complications such as pneumothorax 2, 7

The European Society for Clinical Nutrition and Metabolism (ESPEN) recommends avoiding left-sided central venous access when possible due to increased risk of thrombotic complications compared to right-sided placement 8, 9, 10
The ESPEN guidelines state that right-sided access is preferable to left-sided approach with respect to risk for thrombotic complications, based on evidence from 2021 and 2023 guidelines 8, 9, 10
The anatomical path from the left internal jugular or subclavian vein requires the catheter to traverse a less direct route, increasing vessel wall trauma, according to the 2009 Clinical Nutrition journal 11, 12
Tip malposition is more common with left-sided catheters due to the angulated course, as noted in the 2009 Clinical Nutrition journal 11, 12

The first choice for central line placement should be the right internal jugular vein with ultrasound guidance, as recommended by the 2021 Clinical Nutrition journal 8, 9, 10
The right subclavian vein is the second choice, but should be avoided in patients with advanced kidney disease or hemodialysis, with a higher pneumothorax risk than internal jugular, as noted in the Clinical Nutrition journal 12
Left-sided access should only be considered when right-sided vessels are thrombosed or stenotic, or in cases of previous right-sided infection or trauma, as stated in the 2021 Clinical Nutrition journal 9